Background Medicinal cannabis has received increased research attention over recent
years due to loosening global regulatory changes. Medicinal cannabis has been reported to …

We conducted a systematic review of meta-analyses and systematic reviews to evaluate the
impact of cannabis use on the onset and course of psychoses. Following a systematic …

The sale of cannabis for adult recreational use has been made legal in nine US states since
2012, and nationally in Uruguay in 2013 and Canada in 2018. We review US research on …

The Hierarchical Taxonomy of Psychopathology (HiTOP) is a scientific effort to address
shortcomings of traditional mental disorder diagnoses, which suffer from arbitrary …

Abstract Background and Aims Cannabis products are becoming increasingly diverse, and
vary considerably in concentrations of∆ 9‐tetrahydrocannabinol (THC) and cannabidiol …

Cannabis is the third most used psychoactive substance worldwide. The legal status of
cannabis is changing in many Western countries, while we have very limited knowledge of …

The identification of the human cannabinoid receptors and their roles in health and disease,
has been one of the most significant biochemical and pharmacological advancements to …

Twenty percent of individuals at clinical high risk for psychosis (CHR-P) develop the disorder
within 2 years. Extensive research has explored the factors that differentiate those who …

Objective: This review discusses the relationship between cannabis use and psychotic,
bipolar, depressive, and anxiety disorders, as well as suicide. It summarizes epidemiological …

Background: The landscape of attitudes, legal status and patterns of use of cannabis is
rapidly changing in the United States and elsewhere. Therefore, the primary aim of this …